Stockwatch: Esperion – Bonfire Of The Surrogates
Surrogate Markers Of Sales And Efficacy Have Not Impressed In A Pandemic
Executive Summary
For a biotech launching its first product the pandemic has compounded the usual pressures of a competitive indication against deeper-pocketed competition.